New York State Common Retirement Fund Grows Stock Position in American Healthcare REIT, Inc. (NYSE:AHR)

New York State Common Retirement Fund lifted its stake in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 58.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,100 shares of the company's stock after purchasing an additional 12,600 shares during the quarter. New York State Common Retirement Fund's holdings in American Healthcare REIT were worth $969,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Wilmington Savings Fund Society FSB purchased a new position in American Healthcare REIT in the third quarter worth $28,000. GAMMA Investing LLC raised its position in American Healthcare REIT by 104.1% in the fourth quarter. GAMMA Investing LLC now owns 988 shares of the company's stock worth $28,000 after acquiring an additional 504 shares in the last quarter. Carolina Wealth Advisors LLC purchased a new position in American Healthcare REIT in the fourth quarter worth $29,000. Quarry LP purchased a new position in American Healthcare REIT in the third quarter worth $33,000. Finally, Decker Retirement Planning Inc. purchased a new position in American Healthcare REIT in the fourth quarter worth $37,000. Hedge funds and other institutional investors own 16.68% of the company's stock.

American Healthcare REIT Stock Up 2.3 %

AHR opened at $30.49 on Tuesday. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.59. The firm has a market cap of $4.67 billion and a P/E ratio of -63.52. American Healthcare REIT, Inc. has a 52 week low of $12.81 and a 52 week high of $30.97. The business's fifty day simple moving average is $28.42 and its 200 day simple moving average is $26.47.

American Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Tuesday, December 31st were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.28%. The ex-dividend date was Tuesday, December 31st. American Healthcare REIT's payout ratio is currently -370.37%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Royal Bank of Canada upped their target price on American Healthcare REIT from $28.00 to $30.00 and gave the company an "outperform" rating in a report on Monday, November 18th. Truist Financial upped their target price on American Healthcare REIT from $27.00 to $29.00 and gave the company a "buy" rating in a report on Friday, November 15th. Finally, Morgan Stanley upped their target price on American Healthcare REIT from $27.00 to $29.00 and gave the company an "overweight" rating in a report on Monday, December 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $26.00.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.